Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab.

Cell reports·2026
Same author

Rapid LC-MS/MS Method for Targeted Assay of Creatine Deficiency Syndromes in Morocco.

Metabolites·2026
Same author

Human papillomavirus genotypes and factors associated with major cervical smear abnormalities in a sickle cell endemic area of Kisangani, Democratic Republic of the Congo.

PloS one·2026
Same author

Health economic evaluations of genomic newborn screening: Approaches by studies within the international consortium on newborn sequencing.

European journal of human genetics : EJHG·2026
Same author

A Validated Prognostic Score for Time to Loss of Ambulation in Patients With Duchenne Muscular Dystrophy.

Neurology·2026
Same author

Genomic newborn screening for actionable, sight-threatening eye diseases.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026

Related Experiment Video

Updated: Jan 14, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.5K

Analytical Validation of a Genomic Newborn Screening Workflow.

Kristine Hovhannesyan1, Laura Helou2, Benoit Charloteaux2

  • 1Biochemical Genetics Laboratory, CHU of Liege, University of Liege, Avenue de l'Hôpital 1, 4000 Liege, Belgium.

International Journal of Neonatal Screening
|October 24, 2025
PubMed
Summary

Gene panel sequencing expands newborn screening (NBS) to cover more treatable rare diseases. This validated workflow is accurate, scalable, and addresses critical gaps in current screening programs.

Keywords:
BabyDetectanalytical validationdried blood spotgenomicnewborn screeningnext generation sequencing

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K
Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
09:16

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

20.4K

Related Experiment Videos

Last Updated: Jan 14, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.5K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K
Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
09:16

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

20.4K

Area of Science:

  • Genomics
  • Medical Diagnostics
  • Rare Diseases

Background:

  • Newborn screening (NBS) currently misses many treatable rare diseases due to technical limitations.
  • Conventional biochemical screening methods have inherent limitations in detecting a wide spectrum of rare conditions.

Purpose of the Study:

  • To analytically validate a gene panel sequencing workflow for expanding NBS.
  • To assess the feasibility, accuracy, and scalability of gene panel sequencing for detecting treatable rare diseases.

Main Methods:

  • Analytical validation using dried blood spots from newborns.
  • Implementation of strict quality control for sequencing, coverage, and contamination.
  • Longitudinal monitoring of performance across over 5900 samples.

Main Results:

  • The gene panel sequencing workflow demonstrated high sensitivity, precision, and reproducibility.
  • Automated DNA extraction enhanced scalability, and panel redesign improved target region coverage.
  • Focusing on known pathogenic variants minimized false positives, maintaining clinical actionability.

Conclusions:

  • Gene panel sequencing-based NBS is a feasible and accurate method for expanding screening.
  • This approach effectively addresses critical gaps in current newborn screening programs for rare diseases.
  • The validated workflow offers a scalable solution for broader NBS coverage.